[The safety and efficacy of saquinavir in the therapy of HIV infection].
D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D015497:HIV-1; D006801:Humans; D007546:Isoquinolines / Q000009:adverse effects / Q000627:therapeutic use*; D011804:Quinolines / Q000009:adverse effects / Q000627:therapeutic use*; D019258:Saquinavir
D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D011804:Quinolines; D019258:Saquinavir
Sicherheit und Wirksamkeit von Saquinavir in der Therapie der HIV-Infektion.